Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Moodys
Dow
Harvard Business School
Baxter

Last Updated: June 27, 2022

CLINICAL TRIALS PROFILE FOR DUREZOL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Durezol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01124045 ↗ Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery Completed Alcon Research Phase 3 2010-08-01 The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age.
NCT01201798 ↗ Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Completed Alcon Research Phase 3 2010-10-01 The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis.
NCT01244334 ↗ Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Completed Alcon Research Phase 4 2009-03-01 The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness.
NCT01244334 ↗ Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Completed Parsons Medical Communications Phase 4 2009-03-01 The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness.
NCT01244334 ↗ Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Completed Sirion Therapeutics, Inc. Phase 4 2009-03-01 The purpose of this clinical research study is to investigate the efficacy of predosing patients undergoing cataract surgery with the potent corticosteroid difluprednate ophthalmic emulsion 0.05% compared to prednisolone acetate 1% on corneal edema (swelling), and retinal thickness.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Durezol

Condition Name

Condition Name for Durezol
Intervention Trials
Cataracts 2
Retinal Structural Change, Deposit and Degeneration 1
Uveitis 1
Visual Acuity Reduced Transiently 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Durezol
Intervention Trials
Cataract 3
Uveitis 2
Edema 2
Uveitis, Anterior 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Durezol

Trials by Country

Trials by Country for Durezol
Location Trials
United States 8
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Durezol
Location Trials
Texas 3
Florida 1
California 1
South Carolina 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Durezol

Clinical Trial Phase

Clinical Trial Phase for Durezol
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Durezol
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Durezol

Sponsor Name

Sponsor Name for Durezol
Sponsor Trials
Alcon Research 4
Aravind Eye Hospitals, India 1
University of California, San Francisco 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Durezol
Sponsor Trials
Industry 6
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
AstraZeneca
Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.